Predicting the Outcome of ADHD in White Matter Injure Neonates With Multi-modality MRI
Key facts
- Who runs it
- First Affiliated Hospital Xi'an Jiaotong University
- Where
- China9 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 348 people enrolled
- Started
- 29 Jan 2023
- Ended
- 30 May 2025
- Type of study
- Observational, 2 groups
- Record updated
- 23 September 2026
Who can take part
- Age
- 1 day and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Neonates diagnosed with white matter injury (WMI) or neonates without obvious abnormalities on routine MRI examination from the multicenter database
- Brain MRI examination performed within 28 days after birth, with gestational age ≤42 weeks at examination
- Complete MRI data available, including T1-weighted imaging (T1WI), T2-weighted imaging (T2WI), and diffusion tensor imaging (DTI)
- Complete maternal and pregnancy history information, neonatal demographic characteristics, and clinical information available
Who cannot take part
- Congenital nervous system developmental malformations or suspected genetic or metabolic diseases
- Obvious MRI artifacts affecting image evaluation
- Inability to complete follow-up neurobehavioral assessments
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this bidirectional observational cohort study is to investigate the longitudinal relationship between neonatal white matter injury (WMI) and the subsequent development of attention-deficit/hyperactivity disorder (ADHD), and to identify early MRI-based markers associated with ADHD-related outcomes. The study includes both retrospective and prospective cohorts to dynamically evaluate the evolution of brain injury, brain development, and behavioral outcomes from infancy to childhood.
Read full original descriptionShow less
The main questions it aims to answer are:
Are neonatal WMI characteristics associated with the subsequent development of ADHD? Which MRI-derived features, including semi-quantitative WMI assessment, microstructural alterations, and structural disconnection patterns, are associated with ADHD-related outcomes?
Participants with neonatal WMI will undergo longitudinal clinical, neurodevelopmental, and behavioral follow-up. Researchers will analyze clinical information and MRI findings to characterize WMI evolution and identify imaging markers associated with ADHD risk. Participants will:
undergo brain MRI examinations according to clinical protocols; receive standardized neurodevelopmental and behavioral assessments during follow-up; have MRI-derived measures, including semi-quantitative WMI scores, white matter microstructural features, and structural disconnection measures, analyzed to investigate their associations with ADHD-related outcomes.
The 2 groups in the trial
- White matter injure group
Neonates presented with punctate, linear, or clustered white matter lesions at the center of the semiovale and lateral ventricles, with TIWI hyper-intensive s and with or without T2WI hypointensity.
- Control group
No abnormal signals are found on both conventional and diffusion images. SWI and ASL are also considered when necessary.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Multi-center Longitudinal Clinical Study on the Evolution of Neonatal White Matter Injure to ADHD Based on Multi-modality MRI
- Record updated
- 23 September 2026